S&P Futures
5,889.50 -3.00 (-0.05%) Dow Futures
43,038.00 -131.00 (-0.30%) Nasdaq Futures
20,515.50 -26.50 (-0.13%) Russell 2000 Futures
2,242.80 -3.40 (-0.15%) Crude Oil
71.24 -0.50 (-0.70%) Gold
2,769.30 +9.50 (+0.34%)
Rhythm Pharmaceuticals, Inc. (RYTM)
After hours:
| Previous Close | 50.19 |
| Open | 49.69 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 49.06 - 50.41 |
| 52 Week Range | 21.63 - 55.64 |
| Volume | |
| Avg. Volume | 395,330 |
| Market Cap | 3.004B |
| Beta (5Y Monthly) | 2.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.35 |
| Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 60.64 |
Simply Wall St.High Growth Tech Stocks to Watch in October 2024
The United States market has experienced a notable upswing, climbing 1.5% in the last week and achieving a 33% increase over the past year, with earnings anticipated to grow by 16% annually in the coming years. In this context of robust market performance, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and adaptability to capitalize on these favorable conditions.
GlobeNewswireRhythm Pharmaceuticals Announces New Employment Inducement Grants
BOSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that on October 4, 2024, the Compensation & Management Development Committee of Rhythm’s Board of Directors granted inducement restricted stock units, or RSUs, covering an aggregate of 30,050 shares of its common stock to nine new employees. These inducement RSUs
